Viridian Therapeutics Inc (VRDN)
Healthcare
Biotechnology
19.30 $
+2.1%
vs. previous close
Closing price · As of: 3. Aug 2026
Viridian Therapeutics Inc (VRDN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -276 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.2 | -6.9 | -7.2 | -28 | -27 | -36 | -30 | -55 | -94 | -184 | -232 | -276 | |
| 0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.2 | 0.1 | 0.3 | 0.5 | 0.5 | -6.8 | |
| 4.3 | 3.0 | 2.1 | 2.4 | 3.7 | 4.0 | 3.6 | 14 | 20 | 67 | 42 | 44 | |
| – | – | 0.6 | 2.5 | 3.6 | 3.9 | 76 | 22 | 20 | – | – | – | |
| 0.1 | 1.1 | 2.2 | -4.5 | 1.9 | 1.7 | 4.4 | 1.7 | 16 | -9.4 | 9.6 | 23 | |
| 0.3 | 0.1 | 0.0 | 0.2 | 0.4 | 0.1 | 0.0 | 0.3 | 0.8 | 0.9 | 0.5 | 0.5 | |
| -0.3 | -0.1 | 0.0 | 1.0 | -30 | 28 | -50 | -74 | -115 | -94 | -229 | -38 | |
| – | – | – | – | – | – | 0.0 | – | – | 14 | – | – | |
| – | -0.4 | -0.2 | -1.2 | -3.0 | – | 0.0 | 125 | 0.2 | 0.6 | – | 1.1 | |
| – | – | -0.3 | 5.3 | -2.3 | -2.3 | -8.6 | 5.0 | 4.6 | 15 | 0.0 | 29 | |
| 7.4 | 13 | -0.3 | 52 | 42 | 0.1 | 101 | 125 | 322 | 226 | 458 | 427 | |
| 4.9 | 5.7 | -7.5 | 25 | -15 | -7.8 | 21 | -3.6 | 113 | -53 | -3.2 | 113 | |
| -2.5 | -7.0 | -7.2 | -28 | -27 | -36 | -30 | -55 | -95 | -185 | -233 | -277 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.